insights_auto
Why is EDIT down 3,39%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,71 $
arrow_downward
-3,39%(-0,060) 1D
1,77 $
arrow_upward
+3,36% (+0,058)bedtimeAfter hours
Closed: 19 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,80 $
High
1,83 $
Low
1,70 $
Mkt. cap
263,92 մլն
Avg. vol.
2,38 մլն
Volume
0,00
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
1,80 $
High
1,83 $
Low
1,70 $
Mkt. cap
263,92 մլն
Avg. vol.
2,38 մլն
Volume
0,00
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
Benzinga
·
1 ժամ առաջ
Stock Market: Will S&P 500 Open Up or Down Today?
FOREX.com
·
1 ժամ առաջ
S&P 500 Analysis: SPX Is Going Through One of Its Most Difficult Periods of 2026
Adam Feldman | Substack
·
12 ժամ առաջ
Inside the Federal Litigation of Five S&P 500 Giants
BigGo Finance
·
6 ժամ առաջ
Chip ETF Eyes Unprecedented Fourth Straight Year of Beating the S&P 500
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc